Cholesterol metabolites coordinate skin barrier immunity centered on innate dermal gammadelta T cells programmed to produce IL-17

胆固醇代谢物协调以先天真皮 γδ T 细胞为中心的皮肤屏障免疫,这些细胞被编程为产生 IL-17

基本信息

  • 批准号:
    10366952
  • 负责人:
  • 金额:
    $ 70.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-11-01 至 2026-10-31
  • 项目状态:
    未结题

项目摘要

Summary Immunological control of mucosal barrier development and maintenance is a critical process, as imbalances in immune sentinel activity can lead to skin, lung and gut inflammatory diseases. Central in the mucosal tissue homeostasis are type 3 cytokine producing lymphocytes. Cytokines, cytokines receptors and master transcriptions involved in tissue development and barrier fortification have been identified based on analyses of loss of function models in human and mice. However, non-inflammatory factors that orchestrate the type 3 responses in tissues to assure proper immune reactions and prevent aberrant inflammation have not been well characterized. We discovered that oxysterols, a major class of cholesterol metabolites with established immunomodulatory activities, are the primary positional cues for the stereotypical type 3 lymphocytes in the skin called Tγδ17 cells. Ebi2 (encoded by Gpr183) is the G protein coupled receptor (GPCR) that senses specific types of oxysterols, and is expressed on all type 3 cytokine producing lymphocytes. Increased dietary cholesterol enhances Tgd17 activity at the skin interface via augmented oxysterol production and sensing. However, how tissue resident cells contribute to the anatomical framework that generate the final positional cues for dermal IL-17 secreting innate T lymphocytes is not known. Moreover, whether oxysterols are involved in the development of skin-tropic Tgd17 and other type 3 cytokine producing lymphocytes is not known. In this project we will test the hypothesis that Tgd17 cells maintain barrier tissue homeostasis by sensing cues that reflect nutritional states and inputs from the peripheral nerve system. Metabolic changes in the epithelial- neuronal niche in the skin control optimal microanatomical Tgd17 positioning and function via GPR183. This integrated sensory mechanism for cholesterol metabolism and neuronal inputs is imprinted early in Tγδ17 thymocyte maturation through interactions with a novel subset of thymic epithelial cells programmed to produce oxysterols. The conceptual basis of this project is innovative as there are no precedents for the oxysterol- regulated mucosal tissue hub integrating epithelial-neuronal-immune communications critical for barrier tissue fitness.
总结 粘膜屏障发育和维持的免疫学控制是一个关键过程,因为粘膜屏障发育和维持的不平衡。 免疫前哨活动可导致皮肤、肺和肠道炎性疾病。位于粘膜组织中央 体内平衡是产生3型细胞因子的淋巴细胞。细胞因子、细胞因子受体和主 基于对以下方面的分析,已经确定了涉及组织发育和屏障强化的transcription: 人和小鼠的功能丧失模型。然而,协调3型糖尿病的非炎症因子 在组织中确保适当的免疫反应和防止异常炎症的反应并不好 表征了 我们发现氧化固醇,一种主要的胆固醇代谢物,具有既定的免疫调节作用, 活动,是皮肤中称为Tγδ17细胞的定型3型淋巴细胞的主要位置线索。 Ebi 2(由Gpr 183编码)是G蛋白偶联受体(GPCR),其感测特定类型的氧固醇, 并在所有产生3型细胞因子的淋巴细胞上表达。膳食胆固醇增加可提高Tgd 17 通过增加氧固醇的产生和传感,在皮肤界面处的活性。然而,组织驻留细胞 有助于产生真皮IL-17分泌先天性IL-17的最终位置线索的解剖框架, T淋巴细胞是未知的。此外,氧化固醇是否参与皮肤嗜性Tgd 17的发育, 和其它产生3型细胞因子的淋巴细胞是未知的。 在这个项目中,我们将测试Tgd 17细胞通过感知线索来维持屏障组织稳态的假设 反映营养状态和来自周围神经系统的输入。上皮细胞的代谢变化- 皮肤中的神经元小生境通过GPR 183控制最佳的显微解剖学Tgd 17定位和功能。这 胆固醇代谢和神经元输入的综合感觉机制在Tγδ17早期被印记 胸腺细胞成熟通过与一种新的胸腺上皮细胞亚群的相互作用, 氧化固醇该项目的概念基础是创新的,因为没有氧化固醇的先例- 整合上皮-神经元-免疫通讯的受调节粘膜组织枢纽对屏障组织至关重要 健身

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joonsoo Kang其他文献

Joonsoo Kang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joonsoo Kang', 18)}}的其他基金

Identification of lung resident innate lymphocytes that specifically protect neonates from SARS-CoV-2 infections
鉴定可特异性保护新生儿免受 SARS-CoV-2 感染的肺固有淋巴细胞
  • 批准号:
    10742495
  • 财政年份:
    2023
  • 资助金额:
    $ 70.36万
  • 项目类别:
Parsing cholesterol metabolite regulation of skin immunocytes in children to identify archetypes of human neonatal immune system
解析儿童皮肤免疫细胞的胆固醇代谢调节,以确定人类新生儿免疫系统的原型
  • 批准号:
    10435128
  • 财政年份:
    2022
  • 资助金额:
    $ 70.36万
  • 项目类别:
Parsing cholesterol metabolite regulation of skin immunocytes in children to identify archetypes of human neonatal immune system
解析儿童皮肤免疫细胞的胆固醇代谢调节,以确定人类新生儿免疫系统的原型
  • 批准号:
    10595606
  • 财政年份:
    2022
  • 资助金额:
    $ 70.36万
  • 项目类别:
RUNX:CBFb complex constrains fetal-restricted innate T cell generation from adult lymphopoietic progenitors
RUNX:CBFb 复合物限制成人淋巴细胞祖细胞产生胎儿限制的先天 T 细胞
  • 批准号:
    10328570
  • 财政年份:
    2021
  • 资助金额:
    $ 70.36万
  • 项目类别:
Cholesterol metabolites coordinate skin barrier immunity centered on innate dermal gammadelta T cells programmed to produce IL-17
胆固醇代谢物协调以先天真皮 γδ T 细胞为中心的皮肤屏障免疫,这些细胞被编程为产生 IL-17
  • 批准号:
    10514621
  • 财政年份:
    2021
  • 资助金额:
    $ 70.36万
  • 项目类别:
RUNX:CBFb complex constrains fetal-restricted innate T cell generation from adult lymphopoietic progenitors
RUNX:CBFb 复合物限制成人淋巴细胞祖细胞产生胎儿限制的先天 T 细胞
  • 批准号:
    10195780
  • 财政年份:
    2021
  • 资助金额:
    $ 70.36万
  • 项目类别:
Innate T cells learn to find their activating ligands in the skin during their thymic education using cholesterol byproducts
先天 T 细胞在胸腺教育过程中利用胆固醇副产物学会寻找皮肤中的激活配体
  • 批准号:
    9763936
  • 财政年份:
    2019
  • 资助金额:
    $ 70.36万
  • 项目类别:
Identification and single cell analysis of embryonic lymphoid progenitors that generate neonatal innate T cells
产生新生儿先天 T 细胞的胚胎淋巴祖细胞的鉴定和单细胞分析
  • 批准号:
    10159863
  • 财政年份:
    2019
  • 资助金额:
    $ 70.36万
  • 项目类别:
SOX4 and SOX13 control early steps of invariant NKT cell differentiation
SOX4 和 SOX13 控制恒定 NKT 细胞分化的早期步骤
  • 批准号:
    8709664
  • 财政年份:
    2014
  • 资助金额:
    $ 70.36万
  • 项目类别:
Gene circuits programming IL-17 production in innate lymphocytes
基因电路编程先天淋巴细胞中 IL-17 的产生
  • 批准号:
    9194376
  • 财政年份:
    2013
  • 资助金额:
    $ 70.36万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.36万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 70.36万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.36万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.36万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.36万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.36万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.36万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 70.36万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 70.36万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 70.36万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了